The inducible nitric oxide synthase locus confers protection against aerogenic challenge of both clinical and laboratory strains of Mycobacterium tuberculosis in mice.
about
Pathogenesis, immunology, and diagnosis of latent Mycobacterium tuberculosis infectionNitric oxide generated from isoniazid activation by KatG: source of nitric oxide and activity against Mycobacterium tuberculosisTh1 and Th17 Cells in Tuberculosis: Protection, Pathology, and BiomarkersRedox homeostasis in mycobacteria: the key to tuberculosis control?Exploitation of Mycobacterium tuberculosis reporter strains to probe the impact of vaccination at sites of infectionMycobacterium tuberculosis universal stress protein Rv2623 regulates bacillary growth by ATP-Binding: requirement for establishing chronic persistent infectionResistance to first-line anti-TB drugs is associated with reduced nitric oxide susceptibility in Mycobacterium tuberculosisDeletion of the Mycobacterium tuberculosis resuscitation-promoting factor Rv1009 gene results in delayed reactivation from chronic tuberculosisDeletion of the Mycobacterium tuberculosis pknH gene confers a higher bacillary load during the chronic phase of infection in BALB/c miceMycobacterium tuberculosis expresses methionine sulphoxide reductases A and B that protect from killing by nitrite and hypochloriteIdentification of substrates of the Mycobacterium tuberculosis proteasomeSerine protease activity contributes to control of Mycobacterium tuberculosis in hypoxic lung granulomas in miceMycobacterial Metabolic Syndrome: LprG and Rv1410 Regulate Triacylglyceride Levels, Growth Rate and Virulence in Mycobacterium tuberculosisS-nitroso proteome of Mycobacterium tuberculosis: Enzymes of intermediary metabolism and antioxidant defense.Evidence inconsistent with a negative influence of T helper 2 cells on protection afforded by a dominant T helper 1 response against Mycobacterium tuberculosis lung infection in mice.Cell-autonomous effector mechanisms against mycobacterium tuberculosis.New approaches in the diagnosis and treatment of latent tuberculosis infectionExpression of Th1-mediated immunity in mouse lungs induces a Mycobacterium tuberculosis transcription pattern characteristic of nonreplicating persistence.Immunogenicity of a fusion protein containing immunodominant epitopes of Ag85C, MPT51, and HspX from Mycobacterium tuberculosis in mice and active TB infection.Role of the NF-kappaB signaling pathway and kappaB cis-regulatory elements on the IRF-1 and iNOS promoter regions in mycobacterial lipoarabinomannan induction of nitric oxideTuberculosis: new aspects of an old disease.Inhibitory effect of NO-releasing ciprofloxacin (NCX 976) on Mycobacterium tuberculosis survivalProtein energy malnutrition during vaccination has limited influence on vaccine efficacy but abolishes immunity if administered during Mycobacterium tuberculosis infectionMycobacterium tuberculosis Is a Natural Ornithine Aminotransferase (rocD) Mutant and Depends on Rv2323c for Growth on ArginineSerious infections associated with anticytokine therapies in the rheumatic diseases.The pathogenesis of tuberculosis: the first one hundred (and twenty-three) years.Individual Mycobacterium tuberculosis resuscitation-promoting factor homologues are dispensable for growth in vitro and in vivo.Hypercalcaemic crisis in an elderly patient with pulmonary tuberculosis.Interferon γ and Tumor Necrosis Factor Are Not Essential Parameters of CD4+ T-Cell Responses for Vaccine Control of Tuberculosis.Impaired expression of perforin and granulysin in CD8+ T cells at the site of infection in human chronic pulmonary tuberculosis.Virulent but not avirulent Mycobacterium tuberculosis can evade the growth inhibitory action of a T helper 1-dependent, nitric oxide Synthase 2-independent defense in miceHypercholesterolemia impairs immunity to tuberculosisA Mycobacterium tuberculosis Rpf double-knockout strain exhibits profound defects in reactivation from chronic tuberculosis and innate immunity phenotypes.Microenvironments in tuberculous granulomas are delineated by distinct populations of macrophage subsets and expression of nitric oxide synthase and arginase isoforms.The intracellular environment of human macrophages that produce nitric oxide promotes growth of mycobacteria.Compartmentalization of immune responses in human tuberculosis: few CD8+ effector T cells but elevated levels of FoxP3+ regulatory t cells in the granulomatous lesionsType I IFN Inhibits Alternative Macrophage Activation during Mycobacterium tuberculosis Infection and Leads to Enhanced Protection in the Absence of IFN-γ Signaling.Both inducible nitric oxide synthase and NADPH oxidase contribute to the control of virulent phase I Coxiella burnetii infectionsM2 macrophages or IL-33 treatment attenuate ongoing Mycobacterium tuberculosis infection.Adjusting to a new home: Mycobacterium tuberculosis gene expression in response to an intracellular lifestyle.
P2860
Q21296755-094B839C-172C-4235-9572-43E5EEFCA002Q24564370-840C8FBB-F737-42E2-BEF7-0F0810052B13Q26774207-1E9749A3-F51A-4C9E-B69D-2658D601495DQ27012879-48899490-43AC-4531-9006-D83AC8CAF376Q27323963-1B6BACF9-F7D4-4D3B-9525-A7464771BE2BQ28475519-C1F0F44A-F8C8-4272-B757-28B180F1AB18Q28480924-FB587967-26A6-4BE3-9E24-6C644201B135Q28486566-B385825C-47C7-4AD9-A71D-579514101AA2Q28486752-9A0B5AD1-F414-4F9E-86E6-11A3836CEB4AQ28486777-64DEC8DE-B965-4D0D-818F-4E8C98A912D9Q28487088-71B01BA6-D8F3-4637-B4B6-5CF2EB4A756AQ28505858-75F79DFC-99F7-4246-934C-A4C5F514925EQ28552338-EFAA710F-04FF-4154-A3F3-0B6F4B57E1A1Q33722881-15EEC01E-D176-4D96-AA25-7C3BE43A2C44Q34183965-F3DC715A-A117-4279-9937-0738B2F1D4FBQ34287676-85FB8F8E-10B5-484C-8E0D-A4212C8745F3Q34419185-4686F78D-1C45-447C-8A42-10C70FD49167Q34467579-2C3C5E4E-BC7F-4410-BDF5-67CAD3216E82Q34469190-409E2B33-0173-4AD1-8703-11DD7EF3A746Q34714207-1B8C1C7A-2135-467D-B83E-3427474A4E94Q35094378-900600C8-AD00-421E-A7BE-9B35EFD16654Q35102614-DD31966E-6F54-429D-A98A-277B4B385B21Q35439452-81776D1B-0730-483B-AE40-6B182BEDAD88Q35774201-EB50303C-56B1-445B-965C-630A82B2B449Q35937819-2F93940B-40ED-4FF7-9858-6A71EBC60048Q36075177-165D64FD-6107-4F4E-A443-5F984AC21794Q36228330-933A8483-E15E-4481-9A57-2AD2E27F6B6EQ36241676-6321960C-797A-412A-B997-CA398A9C4B5AQ36303844-6BB98AE1-1D4B-4E4E-A233-E68FA515C97BQ36313789-F7520D20-1077-499A-98CA-6869AB252AB5Q36371162-14F50F03-3884-425E-BDEB-9FD6E3A23AE0Q36804177-6D6D9E63-FD95-4BA8-8CE9-749EA3EB3345Q36845283-B4990301-FC65-4CA4-A6FC-FF788784A109Q37103066-28993B7A-0C3F-4E8C-8FA0-B117840A385FQ37123814-9C3E5950-E8BE-42FF-BEC0-49590E3A9A54Q37197377-71FAD653-B4E6-4ABD-BDB0-01370F08CAB4Q37465000-2857D801-773F-49EC-839E-D22D17FF74EAQ37582812-C4334E71-EE1E-4F0C-9662-D1E04947D2FFQ37609295-FF9A0973-CEE5-4C22-A91D-005A77FB9892Q37648714-4EBC42B0-6CC4-489E-A3F4-06CCDE25F86E
P2860
The inducible nitric oxide synthase locus confers protection against aerogenic challenge of both clinical and laboratory strains of Mycobacterium tuberculosis in mice.
description
2001 nî lūn-bûn
@nan
2001 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
The inducible nitric oxide syn ...... acterium tuberculosis in mice.
@ast
The inducible nitric oxide syn ...... acterium tuberculosis in mice.
@en
The inducible nitric oxide syn ...... acterium tuberculosis in mice.
@nl
type
label
The inducible nitric oxide syn ...... acterium tuberculosis in mice.
@ast
The inducible nitric oxide syn ...... acterium tuberculosis in mice.
@en
The inducible nitric oxide syn ...... acterium tuberculosis in mice.
@nl
prefLabel
The inducible nitric oxide syn ...... acterium tuberculosis in mice.
@ast
The inducible nitric oxide syn ...... acterium tuberculosis in mice.
@en
The inducible nitric oxide syn ...... acterium tuberculosis in mice.
@nl
P2093
P2860
P1476
The inducible nitric oxide syn ...... acterium tuberculosis in mice.
@en
P2093
P2860
P304
P356
10.1128/IAI.69.12.7711-7717.2001
P407
P577
2001-12-01T00:00:00Z